Perimeter Medical Imaging AI Inc at Noble Capital Markets Investor Conference (Virtual) Transcript
Alright. Well, thank you, everybody, for joining us today. I'm happy to share the Perimeter Medical Imaging AI story with you all, and thanks to Channelchek for having us at their conference here at NobleCon.
Before I dive in, just a quick reminder that I will be making forward-looking statements throughout the presentation, and I direct you to our filings on SEDAR for a complete discussion and analysis of the risks facing the organization.
So Perimeter Medical Imaging AI is an early-stage medical device company, and we're driven to transform cancer surgery. We're doing that with ultra-high resolution and real-time advanced imaging tools. Serving unmet needs, really across the continuum of care in cancer -- surgical oncology.
The first unmet need that we're addressing with our flagship product today is called intraoperative margin assessment. So in the case of a solid cancer surgery, we'll talk about breast lumpectomies throughout most of the deck. The surgeon would remove that tumor. And today they send the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |